Phase
Condition
Cancer
Treatment
Intervention
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
All patients on oral chemotherapeutic agents
Clinical diagnosis of stage IV breast cancer
Clinical diagnosis of stage III and IV colorectal cancer (not receiving concurrentradiation therapy)
Clinical diagnosis of stage IV non-small cell lung cancer
Clinical diagnosis of stage IV renal cell carcinoma
Clinical diagnosis of stage IV ovarian carcinoma
Clinical diagnosis of multiple myeloma
Clinical diagnosis of chronic myelogenous leukemia on TKI
Clinical diagnosis of myelodysplastic syndrome on Lenalidomide
Adjuvant treatment for Gastro Intestinal Stromal Tumor
Clinical diagnosis of chronic Lymphocytic Leukemia
Clinical diagnosis of metastatic Prostate cancer
Clinical diagnosis of hepatocellular Carcinoma
Clinical diagnosis of stage IV Melanoma
Clinical diagnosis of myelofibrosis/myeloproliferative neoplasms
Age >18 years
ECOG Performance Status <3
Exclusion
Exclusion Criteria:
ECOG Performance Status of 3 and above
Concurrent chemo radiation
Non-English speaker
Clinical diagnosis of dementia, or otherwise unable to give informed consent.
History of non-compliance (defined as the history of 2 or more missed appointmentsin the clinic).
Pregnant patients
Nursing Home Patients
Incarcerated
Study Design
Study Description
Connect with a study center
Albert Einstein Healthcare Network
Philadelphia, Pennsylvania 19141
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.